XML 55 R35.htm IDEA: XBRL DOCUMENT v3.25.0.1
Summary of Significant Accounting Policies - Schedule of Revenues consist of product sales to customers (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Disaggregation of Revenue [Line Items]      
Product sales, net $ 957,797 $ 726,437 $ 517,235
NUPLAZID      
Disaggregation of Revenue [Line Items]      
Product sales, net 609,385 549,248 517,235
DAYBUE      
Disaggregation of Revenue [Line Items]      
Product sales, net $ 348,412 $ 177,189 $ 0